Catherine S Berkey1, Bernard Rosner2, Rulla M Tamimi2, Walter C Willett3, Martha Hickey4, Adetunji Toriola5, A Lindsay Frazier6, Graham A Colditz7. 1. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA, 02115, USA. Catherine.Berkey@channing.harvard.edu. 2. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA, 02115, USA. 3. Departments of Nutrition and Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. 4. Department of Obstetrics and Gynaecology, University of Melbourne and The Royal Women's Hospital, Melbourne, Australia. 5. Division of Public Health Sciences, Department of Surgery, Alvin J Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA. 6. Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. 7. Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.
Abstract
PURPOSE: Body size, from birth throughout adulthood, is associated with breast cancer risk, but few studies have investigated early-life body size and benign breast disease (BBD), a well-established breast cancer risk factor. We consider whether prenatal factors and size at birth, 10, 18 year, and intervening growth, are related to BBD risk. METHODS: The Growing Up Today Study includes 9032 females who completed questionnaires annually from 1996 to 2001, then 2003, 2005, 2007, 2010, and 2013. In 1996, their mothers provided pregnancy-related data. From 2005 to 2013, participants (18 year+) reported whether they had ever been diagnosed with biopsy-confirmed BBD (N = 142 cases). RESULTS: Girls had greater adiposity (BMI; kg/m2) at 10 year if they were larger at birth, if mother's pre-pregnancy BMI was higher, or if gestational weight gain was greater (all p < .01). Maternal height was (positively) associated (p < .05) with adolescent peak height growth velocity (PHV; in./year). Greater 10 year adiposity was associated with lower PHV and less height growth 10-18 year (both p < .01). Adiposity at 10 year was inversely associated with BBD (OR 0.83/(kg/m2), p < .01) as was increasing adiposity 10-18 year (OR 0.85/(kg/m2), p = .01). In a separate model, 10 year height (OR 1.13/in., p = .02) and height growth 10-18 year (OR 1.19/in.; p < .01) were positively associated. PHV was similarly positively associated (OR 2.58, p = .01, fastest versus slowest growth quartiles). In a multivariable model of BBD risk, gestational weight gain (daughters at highest risk if <20 lb gained), PHV (slowest growing girls at lowest risk), age 10 year height (positive), and BMI (inverse) were the most critical childhood risk factors (each p < .05). CONCLUSIONS: Body size factors from pregnancy through adolescence were independently associated with BBD risk in young women.
PURPOSE: Body size, from birth throughout adulthood, is associated with breast cancer risk, but few studies have investigated early-life body size and benign breast disease (BBD), a well-established breast cancer risk factor. We consider whether prenatal factors and size at birth, 10, 18 year, and intervening growth, are related to BBD risk. METHODS: The Growing Up Today Study includes 9032 females who completed questionnaires annually from 1996 to 2001, then 2003, 2005, 2007, 2010, and 2013. In 1996, their mothers provided pregnancy-related data. From 2005 to 2013, participants (18 year+) reported whether they had ever been diagnosed with biopsy-confirmed BBD (N = 142 cases). RESULTS:Girls had greater adiposity (BMI; kg/m2) at 10 year if they were larger at birth, if mother's pre-pregnancy BMI was higher, or if gestational weight gain was greater (all p < .01). Maternal height was (positively) associated (p < .05) with adolescent peak height growth velocity (PHV; in./year). Greater 10 year adiposity was associated with lower PHV and less height growth 10-18 year (both p < .01). Adiposity at 10 year was inversely associated with BBD (OR 0.83/(kg/m2), p < .01) as was increasing adiposity 10-18 year (OR 0.85/(kg/m2), p = .01). In a separate model, 10 year height (OR 1.13/in., p = .02) and height growth 10-18 year (OR 1.19/in.; p < .01) were positively associated. PHV was similarly positively associated (OR 2.58, p = .01, fastest versus slowest growth quartiles). In a multivariable model of BBD risk, gestational weight gain (daughters at highest risk if <20 lb gained), PHV (slowest growing girls at lowest risk), age 10 year height (positive), and BMI (inverse) were the most critical childhood risk factors (each p < .05). CONCLUSIONS: Body size factors from pregnancy through adolescence were independently associated with BBD risk in young women.
Authors: Heather J Baer; Stuart J Schnitt; James L Connolly; Celia Byrne; Walter C Willett; Bernard Rosner; Graham A Colditz Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-12 Impact factor: 4.254
Authors: Chi Gao; Chirag J Patel; Kyriaki Michailidou; Ulrike Peters; Jian Gong; Joellen Schildkraut; Fredrick R Schumacher; Wei Zheng; Paolo Boffetta; Isabelle Stucker; Walter Willett; Stephen Gruber; Douglas F Easton; David J Hunter; Thomas A Sellers; Christopher Haiman; Brian E Henderson; Rayjean J Hung; Christopher Amos; Brandon L Pierce; Sara Lindström; Peter Kraft Journal: Int J Epidemiol Date: 2016-07-17 Impact factor: 7.196
Authors: Elizabeth H Ruder; Joanne F Dorgan; Sibylle Kranz; Penny M Kris-Etherton; Terryl J Hartman Journal: Clin Breast Cancer Date: 2008-08 Impact factor: 3.225
Authors: Xuefen Su; Graham A Colditz; Walter C Willett; Laura C Collins; Stuart J Schnitt; James L Connolly; Michael N Pollak; Bernard Rosner; Rulla M Tamimi Journal: Int J Cancer Date: 2010-01-01 Impact factor: 7.396
Authors: Catherine S Berkey; Rulla M Tamimi; Walter C Willett; Bernard Rosner; Martha Hickey; Adetunji T Toriola; A Lindsay Frazier; Graham A Colditz Journal: Breast Cancer Res Treat Date: 2019-06-20 Impact factor: 4.872
Authors: Mandy Goldberg; Barbara A Cohn; Lauren C Houghton; Julie D Flom; Ying Wei; Piera Cirillo; Karin B Michels; Mary Beth Terry Journal: Am J Epidemiol Date: 2019-09-01 Impact factor: 4.897
Authors: Peter T Campbell; Christine B Ambrosone; Timothy R Rebbeck; Shuji Ogino; Reiko Nishihara; Hugo J W L Aerts; Melissa Bondy; Nilanjan Chatterjee; Montserrat Garcia-Closas; Marios Giannakis; Jeffrey A Golden; Yujing J Heng; N Sertac Kip; Jill Koshiol; X Shirley Liu; Camila M Lopes-Ramos; Lorelei A Mucci; Jonathan A Nowak; Amanda I Phipps; John Quackenbush; Robert E Schoen; Lynette M Sholl; Rulla M Tamimi; Molin Wang; Matty P Weijenberg; Catherine J Wu; Kana Wu; Song Yao; Kun-Hsing Yu; Xuehong Zhang Journal: Cancer Causes Control Date: 2019-05-08 Impact factor: 2.506
Authors: C S Morgen; L Ängquist; J L Baker; A M N Andersen; K F Michaelsen; T I A Sørensen Journal: Int J Obes (Lond) Date: 2017-09-08 Impact factor: 5.095
Authors: Mary E Sehl; Jill E Henry; Anna Maria Storniolo; Patricia A Ganz; Steve Horvath Journal: Breast Cancer Res Treat Date: 2017-03-31 Impact factor: 4.872
Authors: Catherine S Berkey; Rulla M Tamimi; Walter C Willett; Bernard Rosner; Martha Hickey; Adetunji T Toriola; A Lindsay Frazier; Graham A Colditz Journal: NPJ Breast Cancer Date: 2020-11-23
Authors: Minouk J Schoemaker; Hazel B Nichols; Lauren B Wright; Mark N Brook; Michael E Jones; Katie M O'Brien; Hans-Olov Adami; Laura Baglietto; Leslie Bernstein; Kimberly A Bertrand; Marie-Christine Boutron-Ruault; Tonje Braaten; Yu Chen; Avonne E Connor; Miren Dorronsoro; Laure Dossus; A Heather Eliassen; Graham G Giles; Susan E Hankinson; Rudolf Kaaks; Timothy J Key; Victoria A Kirsh; Cari M Kitahara; Woon-Puay Koh; Susanna C Larsson; Martha S Linet; Huiyan Ma; Giovanna Masala; Melissa A Merritt; Roger L Milne; Kim Overvad; Kotaro Ozasa; Julie R Palmer; Petra H Peeters; Elio Riboli; Thomas E Rohan; Atsuko Sadakane; Malin Sund; Rulla M Tamimi; Antonia Trichopoulou; Giske Ursin; Lars Vatten; Kala Visvanathan; Elisabete Weiderpass; Walter C Willett; Alicja Wolk; Jian-Min Yuan; Anne Zeleniuch-Jacquotte; Dale P Sandler; Anthony J Swerdlow Journal: JAMA Oncol Date: 2018-11-08 Impact factor: 31.777